Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$10.5B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.45B |
| 3 |
Altria Group
MO
|
+$625M |
| 4 |
Kraft Heinz
KHC
|
+$570M |
| 5 |
Netflix
NFLX
|
+$526M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.44B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$1.29B |
| 3 |
Wells Fargo
WFC
|
+$875M |
| 4 |
Qualcomm
QCOM
|
+$771M |
| 5 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.07% |
| 2 | Financials | 8.9% |
| 3 | Technology | 7.48% |
| 4 | Consumer Discretionary | 7.12% |
| 5 | Communication Services | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
iShares MSCI New Zealand ETF
ENZL
$82.7M
| $3.72M | ﹤0.01% |
116,287
-49,347
| -30% | -$1.65M |
|
2852
Direxion Daily Financial Bull 3x ETF
FAS
$2.5B
| $3.72M | ﹤0.01% |
148,036
+31,236
| +27% | +$954K |
|
|
ATLS
2853
DELISTED
ATLAS ENERGY GRP,LLC COM UNITS REPSTG LTD (DE)
ATLS
| $3.72M | ﹤0.01% |
1,666,652
-63,390
| -4% | -$210K |
|
2854
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.72B
| $3.72M | ﹤0.01% |
125,996
-38,729
| -24% | -$1.19M |
|
2855
W.R. Berkley
WRB
$26.2B
| $3.72M | ﹤0.01% |
230,688
-325,971
| -59% | -$5.34M |
|
2856
Silgan Holdings
SLGN
$4.46B
| $3.71M | ﹤0.01% |
142,656
-75,846
| -35% | -$2M |
|
2857
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $3.71M | ﹤0.01% |
204,830
-12,340
| -6% | -$239K |
|
|
WBK
2858
DELISTED
Westpac Banking Corporation
WBK
| $3.71M | ﹤0.01% |
176,057
+4,869
| +3% | +$114K |
|
2859
Allient
ALNT
$1.86B
| $3.7M | ﹤0.01% |
311,888
+15,885
| +5% | +$206K |
|
|
PDT
2860
John Hancock Premium Dividend Fund
PDT
$628M
| $3.69M | ﹤0.01% |
294,070
-31,124
| -10% | -$411K |
|
2861
WisdomTree Enhanced Commodity Strategy Fund
GCC
$280M
| $3.69M | ﹤0.01% |
189,595
-1,996
| -1% | -$40.2K |
|
2862
SS&C Technologies
SSNC
$19.3B
| $3.68M | ﹤0.01% |
105,088
+41,958
| +66% | +$1.42M |
|
|
POLY
2863
DELISTED
Plantronics, Inc.
POLY
| $3.68M | ﹤0.01% |
72,382
-49,956
| -41% | -$2.73M |
|
|
KAMN
2864
DELISTED
Kaman Corp
KAMN
| $3.68M | ﹤0.01% |
102,568
-18,156
| -15% | -$711K |
|
2865
Douglas Dynamics
PLOW
$967M
| $3.66M | ﹤0.01% |
184,413
-71,663
| -28% | -$1.52M |
|
2866
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.18B
| $3.66M | ﹤0.01% |
146,484
-9,618
| -6% | -$258K |
|
|
PCN
2867
PIMCO Corporate & Income Strategy Fund
PCN
$883M
| $3.66M | ﹤0.01% |
278,442
+30,883
| +12% | +$416K |
|
2868
iShares Currency Hedged MSCI Emerging Markets
HEEM
$293M
| $3.66M | ﹤0.01% |
174,152
+4,382
| +3% | +$96.8K |
|
2869
Spok Holdings
SPOK
$230M
| $3.65M | ﹤0.01% |
221,540
-45,943
| -17% | -$760K |
|
|
CMRX
2870
DELISTED
Chimerix, Inc.
CMRX
| $3.63M | ﹤0.01% |
95,158
-12,174
| -11% | -$601K |
|
2871
AptarGroup
ATR
$8.43B
| $3.63M | ﹤0.01% |
55,071
-20,627
| -27% | -$1.37M |
|
2872
Hilltop Holdings
HTH
$2.28B
| $3.63M | ﹤0.01% |
183,396
+74,578
| +69% | +$1.6M |
|
|
GBT
2873
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.63M | ﹤0.01% |
+86,057
| New | +$4.06M |
|
|
MDAS
2874
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $3.63M | ﹤0.01% |
180,768
+27,994
| +18% | +$596K |
|
2875
Ultragenyx Pharmaceutical
RARE
$2.6B
| $3.61M | ﹤0.01% |
37,475
-16,289
| -30% | -$1.87M |
|
Similar funds
Morgan Stanley's Q3 2015 Portfolio in Review
As of Q3 2015, Morgan Stanley held 7,097 positions worth $271B, down 6.2% from $289B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley deployed $8.73B of net new capital in Q3 2015, opening 161 new positions and adding to 2,856 existing holdings. Its largest new stake was Kraft Heinz: 7,552,361 shares worth $533M.
By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 11% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was AbbVie, an estimated $1.44B trimmed.
- Morgan Stanley's largest Q3 2015 buy was Kraft Heinz: 7,552,361 shares worth $533M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $10.5B increase.
- Morgan Stanley's biggest Q3 2015 reduction was AbbVie, cutting an estimated $1.44B.
- Morgan Stanley fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $458M.
- Morgan Stanley's ten largest holdings make up 15% of its $271B portfolio in Q3 2015.
- Morgan Stanley opened 161 new positions and closed 377 in Q3 2015.
- Morgan Stanley's portfolio value fell 6.2% quarter-over-quarter to $271B.
Based on Morgan Stanley's 13F filing for Q3 2015, filed 9 Nov 2015.